Taysha Gene Therapies, Inc.TSHANASDAQ
LOADING
|||
Switch Symbol:
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | 26.40% |
| Q2 2025 | 29.40% |
| Q1 2025 | 1.57% |
| Q4 2024 | 2.54% |
| Q3 2024 | -0.84% |
| Q2 2024 | -27.03% |
| Q1 2024 | 62.88% |
| Q4 2023 | 7.56% |
| Q3 2023 | -40.42% |
| Q2 2023 | 58.15% |
| Q1 2023 | -9.72% |
| Q4 2022 | -17.37% |
| Q3 2022 | -28.64% |
| Q2 2022 | -38.44% |
| Q1 2022 | 0.70% |
| Q4 2021 | -4.07% |
| Q3 2021 | 29.00% |
| Q2 2021 | 28.46% |
| Q1 2021 | 94.57% |
| Q4 2020 | 10.88% |
| Q3 2020 | 261.10% |
| Q2 2020 | -44.47% |
| Q1 2020 | 458.66% |
| Q4 2019 | 0.00% |